Duration of trastuzumab for HER2-positive breast cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)678-679
Number of pages2
JournalThe Lancet Oncology
Volume14
Issue number8
DOIs
Publication statusPublished - Jul 2013

ASJC Scopus subject areas

  • Oncology

Cite this